CSF2 and type 1 diabetes mellitus: Unlike our previous findings in NOD mice [18], no T1D-specific polymorphisms were detected in either CSF2 or PTGS2 upstream regulatory regions that directly associated with the increased GM-CSF production or COX2/PGS2 expression seen in at-risk/T1D individuals [7], [11].